The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report
Open accessAbstract
This consensus document is intended to serve 3 functions. First, it standardizes the criteria for diagnosis of chronic graft-versus-host disease (GVHD). Second, it proposes a new clinical scoring system (0-3) that describes the extent and severity of chronic GVHD for each organ or site at any given time, taking functional impact into account. Third, it proposes new guidelines for global assessment of chronic GVHD severity that are based on the number of organs or sites involved and the degree of involvement in affected organs (mild, moderate, or severe). Diagnosis of chronic GVHD requires the presence of at least 1 diagnostic clinical sign of chronic GVHD (e.g., poikiloderma or esophageal web) or the presence of at least 1 distinctive manifestation (e.g., keratoconjunctivitis sicca) confirmed by pertinent biopsy or other relevant tests (e.g., Schirmer test) in the same or another organ. Furthermore, other possible diagnoses for clinical symptoms must be excluded. No time limit is set for the diagnosis of chronic GVHD. The Working Group recognized 2 main categories of GVHD, each with 2 subcategories. The acute GVHD category is defined in the absence of diagnostic or distinctive features of chronic GVHD and includes (1) classic acute GVHD occurring within 100 days after transplantation and (2) persistent, recurrent, or late acute GVHD (features of acute GVHD occurring beyond 100 days, often during withdrawal of immune suppression). The broad category of chronic GVHD includes (1) classic chronic GVHD (without features or characteristics of acute GVHD) and (2) an overlap syndrome in which diagnostic or distinctive features of chronic GVHD and acute GVHD appear together. It is currently recommended that systemic therapy be considered for patients who meet criteria for chronic GVHD of moderate to severe global severity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic graft-versus-host syndrome in man
Shulman, H. M., Sullivan, K. M., Weiden, P. L., McDonald, G. B., Striker, G. E., Sale, G. E., Hackman, R., Tsoi, M.-S., Storb, R., & Donnall Thomas, E. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90380-0 · Cited by 2,406
Self-citationRocha, V., Wagner, J. E., Sobocinski, K. A., Klein, J. P., Zhang, M.-J., Horowitz, M. M., & Gluckman, E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422501 · Cited by 868
Chronic graft-versus-host disease and other late complications of bone marrow transplantation.
Sullivan, K. M., Agura, E. D., Anasetti, C., Appelbaum, F. R., Badger, C. C., Bearman, S. I., Erickson, K., Flowers, M. E. D., Hansen, J. A., & Loughran, T. P. (1991) · PubMed · Cited by 790
Self-citationKollman, C., Howe, C. W. S., Anasetti, C., Antin, J. H., Davies, S. M., Filipovich, A. H., Hegland, J., Kamani, N., Kernan, N. A., King, R., et al. (2001) · Blood · doi:10.1182/blood.v98.7.2043 · Cited by 703
Self-citationMielcarek, M., Martin, P. J., Leisenring, W., Flowers, M. E. D., Maloney, D. G., Sandmaier, B. M., Maris, M. B., & Storb, R. (2003) · Blood · doi:10.1182/blood-2002-08-2628 · Cited by 562
Self-citationLee, S. J. (2002) · Blood · doi:10.1182/blood.v100.2.406 · Cited by 538
Self-citationCutler, C., Giri, S., Jeyapalan, S., Paniagua, D., Viswanathan, A., & Antin, J. H. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3685 · Cited by 432
Flowers, M. E. D., Parker, P. M., Johnston, L. J., Matos, A. V. B., Storer, B., Bensinger, W. I., Storb, R., Appelbaum, F. R., Forman, S. J., Blume, K. G., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0011 · Cited by 421
Self-citationAtkinson, K., Horowitz, M., Gale, R., van Bekkum, D., Gluckman, E., Good, R., Jacobsen, N., Kolb, H., Rimm, A., & Ringden, O. (1990) · Blood · doi:10.1182/blood.v75.12.2459.2459 · Cited by 359
Duration of immunosuppressive treatment for chronic graft-versus-host disease
Stewart, B. L., Storer, B., Storek, J., Deeg, H. J., Storb, R., Hansen, J. A., Appelbaum, F. R., Carpenter, P. A., Sanders, J. E., Kiem, H.-P., et al. (2004) · Blood · doi:10.1182/blood-2004-01-0200 · Cited by 281
Self-citationSTORB, R., PRENTICE, R. L., SULLIVAN, K. M., SHULMAN, H. M., DEEG, H. J., DONEY, K. C., BUCKNER, C. D., CLIFT, R. A., WITHERSPOON, R. P., APPELBAUM, F. A., et al. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-4-461 · Cited by 281
Self-citationRandolph, S. S. B., Gooley, T. A., Warren, E. H., Appelbaum, F. R., & Riddell, S. R. (2004) · Blood · doi:10.1182/blood-2003-07-2603 · Cited by 260
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation
Przepiorka, D., Anderlini, P., Saliba, R., Cleary, K., Mehra, R., Khouri, I., Huh, Y. O., Giralt, S., Braunschweig, I., van Besien, K., et al. (2001) · Blood · doi:10.1182/blood.v98.6.1695 · Cited by 216
Self-citationPredictors of death from chronic graft-versus-host disease after bone marrow transplantation
Wingard, Jr., Piantadosi, S., Vogelsang, G., Farmer, E., Jabs, D., Levin, L., Beschorner, W., Cahill, R., Miller, D., & Harrison, D. (1989) · Blood · doi:10.1182/blood.v74.4.1428.1428 · Cited by 214
Self-citationCarlens, S., Ringdén, O., Remberger, M., Lönnqvist, B., Hägglund, H., Klaesson, S., Mattsson, J., Svahn, B.-M., Winiarski, J., Ljungman, P., et al. (1998) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701423 · Cited by 211
Remberger, M., Kumlien, G., ASCHAN, J., Barkholt, L., Hentschke, P., Ljungman, P. T., Mattsson, J., Svennilson, J., & Ringdén, O. T. H. (2002) · Transplantation and Cellular Therapy · doi:10.1053/bbmt.2002.v8.abbmt080674 · Cited by 89
Ochs, L., Miller, W. J., Filipovich, A. H., Haake, R. J., McGlave, P. B., Blazar, B. R., Ramsay, N. K. C., Kersey, J. H., & Weisdorf, D. J. (1994) · PubMed · Cited by 89
Self-citation
Cited by
Jagasia, M. H., Greinix, H. T., Arora, M., Williams, K. M., Wolff, D., Cowen, E. W., Palmer, J., Weisdorf, D., Treister, N. S., Cheng, G.-S., et al. (2015) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2014.12.001 · Cited by 5,459
Self-citationFerrara, J. L., Levine, J. E., Reddy, P., & Holler, E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60237-3 · Cited by 2,464
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
Koreth, J., Matsuoka, K.-I., Kim, H. T., McDonough, S. M., Bindra, B., Alyea, E. P., Armand, P., Cutler, C., Ho, V. T., Treister, N. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108188 · Cited by 1,119
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
Anasetti, C., Logan, B. R., Lee, S. J., Waller, E. K., Weisdorf, D. J., Wingard, J. R., Cutler, C. S., Westervelt, P., Woolfrey, A., Couban, S., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203517 · Cited by 920
Self-citationPathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets
Zeiser, R., & Blazar, B. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1703472 · Cited by 748
Metadata
- Authors
- Filipovich, A. H., Weisdorf, D., Pavletic, S., Socie, G., Wingard, J. R., Lee, S. J., Martin, P., Chien, J., Przepiorka, D., Couriel, D., Cowen, E. W., Dinndorf, P., Farrell, A., Hartzman, R., Henslee-Downey, J., Jacobsohn, D., McDonald, G., Mittleman, B., Rizzo, J. D., Robinson, M., Schubert, M., Schultz, K., Shulman, H., Turner, M., Vogelsang, G., & Flowers, M. E. D.
- Venue
- Biology of Blood and Marrow Transplantation
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 11
- Issue
- 12
- Pages
- 945-956
- ISSN
- 1083-8791 (ISSN-L)
- OpenAlex
- W2618073389
- Cited by
- 3,556
- References
- 17
- FWCI
- 23.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.